Funding Details
- Awarder
- Inbox
- Date Award
- October 12, 2016
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Founders
- Professor John Williams, Professor Ulrich Rodeck
- Company Description
- Akriveia Therapeutics is discovering and developing the next generation of cancer immunotherapies. Akriveia's new agents offer the promise of a safer and more efficacious approach to harness a patient's own immune system to fight cancer.
- Market
- Cancer Immunotherapy
- Location
-
Skillman,
NJ,
USA
Links